Fellows' Journal Club
Schedule
Wednesday, Thursday
Noon-1:00 PM (alternates with Tumor Board)
11th Floor Mid-Campus Center, North Conference Room
2020-2021 Academic Year
| Date | Speaker | Title | Download |
| Apr 7, 2021 | Alice Zhou | Gastrointestinal Cancer Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma |
➤ PubMed |
| Bindiya Patel | Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer | ➤ PubMed | |
| Apr 21, 2021 | Miriam Jacobs | Genitourinary Cancers Lenvatinib Plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma |
➤ PubMed |
| Dhruv Bansal | Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma | ➤ PubMed | |
| Apr 29, 2021 | Vanessa Eulo | Breast Cancer Efficacy of Margetuximab Vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial |
➤ PubMed |
| Gradon Nielsen | Pembrolizumab for Early Triple-Negative Breast Cancer | ➤ PubMed | |
| May 6, 2021 | David Russler-Germain | Melanoma Five-Year Analysis of Adjuvant Dabrafenib Plus Trametinib in Stage III Melanoma |
➤ PubMed |
| Michael Kramer | Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients | ➤ PubMed | |
| May 13, 2021 | Raya Saba | Benign Hematology / Myeloma Long-Term Outcomes With Emicizumab Prophylaxis for Hemophilia A With or Without FVIII Inhibitors From the HAVEN 1-4 Studies |
➤ PubMed |
| Zach Crees | Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma | ➤ PubMed | |
| May 25, 2021 | Michael Slade | Thrombosis / Bleeding Disorders | |
| Fahrettin Covut | |||
| Jun 1, 2021 | Lauren Shea | Lymphoma | |
| Mary-Kate Malecek | |||
| Jun 9, 2021 | Ryan Day | Leukemia | |
| Scott Goldsmith | |||
| Jun 16, 2021 | Andrew Young | Gyn Onc Malignancies | |
| Michael Iglesia | |||
| Jun 24, 2021 | Jing Xi | Lung Cancer | |
| Whitney Hensing |
